{"id":"NCT03950856","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020)","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled, Lot-to-Lot Consistency Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Adults 50 Years of Age or Older (PNEU-TRUE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-06-12","primaryCompletion":"2020-04-03","completion":"2020-04-03","firstPosted":"2019-05-15","resultsPosted":"2021-04-12","lastUpdate":"2021-04-12"},"enrollment":2340,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Infections","Pneumonia, Pneumococcal"],"interventions":[{"type":"DRUG","name":"V114","otherNames":[]},{"type":"DRUG","name":"Prevnar 13™","otherNames":[]}],"arms":[{"label":"V114 Lot 1","type":"EXPERIMENTAL"},{"label":"V114 Lot 2","type":"EXPERIMENTAL"},{"label":"V114 Lot 3","type":"EXPERIMENTAL"},{"label":"Prevnar 13™","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objectives are to evaluate the safety and tolerability of V114 and to compare the serotype-specific opsonophagocytic activity (OPA) geometric mean titers (GMTs) across 3 different lots of V114. The primary hypothesis is that all 3 lots of V114 are equivalent as measured by the serotype-specific OPA GMTs for 15 serotypes in V114 at 30 days postvaccination.","primaryOutcome":{"measure":"Percentage of Participants With a Solicited Injection-site Adverse Event Following Vaccination With Separate V114 Lots","timeFrame":"Up to Day 5","effectByArm":[{"arm":"V114 Lot 1","deltaMin":10.2,"sd":null},{"arm":"V114 Lot 2","deltaMin":11.5,"sd":null},{"arm":"V114 Lot 3","deltaMin":11,"sd":null}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":18},"locations":{"siteCount":55,"countries":["United States","Australia","Chile","Denmark","Finland","United Kingdom"]},"refs":{"pmids":["35039194"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":699},"commonTop":["Injection site pain","Myalgia","Fatigue","Headache","Injection site swelling"]}}